Evidence map›Paper›PMID 33089127›Full record

ArticleEClinicalMedicine2020

A developmental and sequenced one-to-one educational intervention (DS1-EI) for autism spectrum disorder and intellectual disability: A three-year randomized, single-blind controlled trial.

Catherine Saint-Georges, Maryse Pagnier, Zeineb Ghattassi, Annick Hubert-Barthelemy, Antoine Tanet, Marie-Noëlle Clément, François Soumille, Graciela C Crespin, Hugues Pellerin, David Cohen and 1 more

Open access · goldAbstract read
In one paragraph

Article in EClinicalMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Catherine Saint-GeorgesInstitut des Systèmes Intelligents et de Robotiques, Sorbonne Université, 75005, Paris, France.
Maryse PagnierDépartement de Psychiatrie de l'Enfant et de l'Adolescent, APHP, Groupe Hospitalier Pitié-Salpêtrière et Sorbonne Université, 47 bd de l'Hôpital, 75013 Paris, France.
Zeineb GhattassiDépartement de Psychiatrie de l'Enfant et de l'Adolescent, APHP, Groupe Hospitalier Pitié-Salpêtrière et Sorbonne Université, 47 bd de l'Hôpital, 75013 Paris, France.
Annick Hubert-BarthelemyDépartement de Psychiatrie de l'Enfant et de l'Adolescent, APHP, Groupe Hospitalier Pitié-Salpêtrière et Sorbonne Université, 47 bd de l'Hôpital, 75013 Paris, France.
Antoine TanetDépartement de Psychiatrie de l'Enfant et de l'Adolescent, APHP, Groupe Hospitalier Pitié-Salpêtrière et Sorbonne Université, 47 bd de l'Hôpital, 75013 Paris, France.
Marie-Noëlle ClémentHôpital de jour André Boulloche, Association Cerep-Phymentin, 56 rue du Faubourg Poissonnière, 75010 Paris, France.
François SoumilleAssociation Régionale pour l'Intégration, 26 rue Saint Sébastien, 13006 Marseille, France.
Graciela C CrespinAssociation Programme de Recherche et d'Etudes sur l'Autisme, 7, Square Dunois, 75013 Paris, France.
Hugues PellerinDépartement de Psychiatrie de l'Enfant et de l'Adolescent, APHP, Groupe Hospitalier Pitié-Salpêtrière et Sorbonne Université, 47 bd de l'Hôpital, 75013 Paris, France.
David CohenInstitut des Systèmes Intelligents et de Robotiques, Sorbonne Université, 75005, Paris, France.
GPIS study group
Sorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChildren with autism spectrum disorder (ASD) and intellectual disability (ID) are an understudied population whose school inclusion is challenging.

methodsWe assessed the effects of "Developmental and Sequenced one-to-one Educational Intervention" (DS1-EI), a ten-hour-per-week adapted instruction programme for five- to nine-year-old children with ASD and ID treated in outpatient health care institutions. A single-blind multisite randomized controlled trial was conducted to compare DS1-EI given for three years with treatment as usual (TAU)(trial registration numbers: ANSM130282B-31 (April 16, 2013) and ACTRN12616000592448). The primary outcome was the change in the psycho-educational profile (PEP). Secondary variables included the Childhood Autism Rating Scale (CARS), Autism Diagnostic Interview-Revised (ADI-R), Vineland Adaptive Behaviour Scale-II (VABS-II), Children's Global Assessment Scale (CGAS) and annual assessment of educational achievement. Statistical analyses used linear mixed models.

findingsSeventy-two participants with severe ASD and ID were recruited. Intention-to-treat and per-protocol analyses showed no significant group*time interaction for the PEP, CARS, ADI-R, VABS-II and CGAS but a significant effect for educational achievement with a better improvement in the DS1-EI group. At the 36-month time point, more DS1-EI children were included in mainstream classrooms. Additional analyses using multivariate models taking into account moderating variables at the baseline (e.g., Developmental Quotient) confirmed that DS1-EI had a significant effect on educational outcomes.

interpretationDS1-EI did not improve communication or social skills in children with ASD and ID compared with TAU. However, DS1-EI enhanced school skills in four domains (language, mathematics, inter modality, and school autonomy) favouring inclusion in mainstream classrooms more than TAU. Providing such adapted instruction is feasible and should be encouraged.

fundingCNSA; Fondation Bettencourt-Schueller; Fondation EDF.

Indexed as

Autism spectrum disorder (ASD)Developmental interventionsIntellectual disability (ID)Randomized controlled trial (RCT)Special education (school)

Identifiers

PMID33089127
PMCPMC7565367
OpenAlexW3083885188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.